Premium
An in vivo study of Cdh1/APC in breast cancer formation
Author(s) -
Fujita Takeo,
Liu Weijun,
Doihara Hiroyoshi,
Wan Yong
Publication year - 2009
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.24399
Subject(s) - cdh1 , breast cancer , cancer research , skp2 , ubiquitin ligase , carcinogenesis , in vivo , cancer , biology , cell growth , medicine , ubiquitin , cell , cadherin , biochemistry , genetics , gene
Abstract Dysregulation of the ubiquitin‐proteasome system (UPS) has been implicated in several types of tumorigenesis. Our previous studies have shown the potential role of Cdh1/APC in regulating tumor formation via governing the Skp2‐p27‐cyclinE/CDK2 axis. In this work, we used a xenograft mouse breast cancer model to identify the mechanism by which Cdh1/APC potentially suppresses tumor growth in vivo . Here, we report that depletion of Cdh1 results in a significant enhancement of the breast tumor proliferation, while elevated Cdh1 leads to suppression of breast tumor growth. Analysis of breast tissue arrays has indicated that higher levels of Cdh1 are associated with normal breast epithelial tissues whereas lower Skp2 expression and elevated p27 levels are detected. Conversely, the percentage of breast cancer tissues stained positive for Cdh1 and p27 are significantly lower with higher Skp2 levels. Thus, the E3 ligase, Cdh1/APC, may inhibit breast tumor growth via regulating Skp2‐p27 mediated cell cycle progression. © 2009 UICC